Health
Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase – USA TODAY
As the nation revs up its vaccination programs, the increase could help relieve bottlenecks caused by vaccine shortages.
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa. (Jan 8)
AP Domestic
Pfizer expects to nearly cut in half the amount of time it takes to produce a batch of COVID-19 vaccine, from 110 days to an average of 60, as it makes the process more efficient and production is built out, the company told USA TODAY.
As…
-
Business21 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News21 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business20 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News20 hours agoDid AI write your accounting expert’s report? – Proctor